Cited by 837Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder ResearchDevelopmental and Educational Neuropsychology

Attention-deficit hyperactivity disorder

Open access
Posner, Jonathan, Polanczyk, Guilherme V, Sonuga-Barke, Edmund·2020·The Lancet

Abstract

Attention-deficit hyperactivity disorder (ADHD), like other psychiatric disorders, represents an evolving construct that has been refined and developed over the past several decades in response to research into its clinical nature and structure. The clinical presentation and course of the disorder have been extensively characterised. Efficacious medication-based treatments are available and widely used, often alongside complementary psychosocial approaches. However, their effectiveness has been questioned because they might not address the broader clinical needs of many individuals with ADHD, especially over the longer term. Non-pharmacological approaches to treatment have proven less effective than previously thought, whereas scientific and clinical studies are starting to fundamentally challenge current conceptions of the causes of ADHD in ways that might have the potential to alter clinical approaches in the future. In view of this, we first provide an account of the diagnosis, epidemiology, and treatment of ADHD from the perspective of both the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders and the eleventh edition of the International Classification of Diseases. Second, we review the progress in our understanding of the causes and pathophysiology of ADHD on the basis of science over the past decade or so. Finally, using these discoveries, we explore some of the key challenges to both the current models and the treatment of ADHD, and the ways in which these findings can promote new perspectives.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)33004-1

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [33]NICE. Attention deficit hyperactivity disorder: diagnosis and management. 3, 2018 https://www.nice.org.uk/guidance/ng87 (accessed Dec 23, 2019). 29634174
  2. [35]Pliszka S Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007; 46: 894– 921. 17581453
  3. [66]Chang Z, Ghirardi, Quinn PD, Asherson P, D’Onofrio BM, Larsson H. Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Bio Psychiatry 2019; 86: 335– 43. 31155139 PMC6697582

Cited by

Sorted by citations

Authors
Posner, J., Polanczyk, G. V., & Sonuga-Barke, E.
Affiliations
  • New York State Psychiatric Institute (US)
  • Universidade de São Paulo (BR)
  • King's College London (GB)
Corresponding author
Posner, Jonathan
Venue
The Lancet
Publisher
Elsevier BV
Published
2020-02
Volume
395
Issue
10222
Pages
450-462
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4211094461
Cited by
835
References
131
Citations by year
2026: 119 · 2025: 176 · 2024: 156 · 2023: 143 · 2022: 127 · 2021: 88 · 2020: 26
FWCI
15.89
Type
journal article
Language
en
Open access
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UH3OD023328)
  • National Institute of Mental Health (R01MH101172, R01MH121070)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
Keywords
attention deficit hyperactivity disorder, ADHD diagnosis, DSM-5, ICD-11, pharmacotherapy, psychosocial interventions, non-pharmacological treatment, pathophysiology, ADHD etiology, treatment effectiveness
MeSH terms
Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Humans, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review